Kynurenine pathway metabolomic profiling in the progression of Multiple Sclerosis: Development of novel biomarker to assess disease severity and therapeutic regimen

Guillemin, Gilles (Primary Chief Investigator)
Lim, Edwin (Chief Investigator)
Brew, Bruce (Chief Investigator)

Project: Research

Status	Finished
Effective start/end date	23/01/13 → 31/12/14

3 Article

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
Sundaram, G., Lim, C. K., Brew, B. J. & Guillemin, G. J., 6 Jun 2020, In: Journal of Neuroinflammation. 17, 1, p. 1-14 14 p., 176.
Research output: Contribution to journal › Article › peer-review

Open Access
File
45 Citations (Scopus)

62 Downloads (Pure)
Involvement of the kynurenine pathway in human glioma pathophysiology
Adams, S., Teo, C., McDonald, K. L., Zinger, A., Bustamante, S., Lim, C. K., Sundaram, G., Braidy, N., Brew, B. J. & Guillemin, G. J., 17 Oct 2014, In: PLoS ONE. 9, 11, p. 1-28 28 p., 0112945.
Research output: Contribution to journal › Article › peer-review

Open Access
File
99 Citations (Scopus)

121 Downloads (Pure)
Quinolinic acid toxicity on oligodendroglial cells: Relevance for multiple sclerosis and therapeutic strategies
Sundaram, G., Brew, B. J., Jones, S. P., Adams, S., Lim, C. K. & Guillemin, G. J., 13 Dec 2014, In: Journal of Neuroinflammation. 11, p. 1-11 11 p., 204.
Research output: Contribution to journal › Article › peer-review

Open Access
File
57 Citations (Scopus)

126 Downloads (Pure)